The expression of miR-21 and miR-143 is deregulated by the HPV16 E7 oncoprotein and 17-estradiol

International Journal of Oncology

Volumn 49, Issue 2, 2016, Pages 549-558

  Gómez Gómez, Yazmín ^a,b   Organista Nava, Jorge ^a,b   Ocadiz Delgado, Rodolfo ^b   García Villa, Enrique ^b   Leyva Vazquez, Marco Antonio ^c   Illades Aguiar, Berenice ^c   Lambert, Paul F ^d   García Carrancá, Alejandro ^e   Gariglio, Patricio ^b  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c Guerrero State University   (Mexico)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cervical cancer; E7 oncoprotein; Estrogens; MiR 143; MiR 21

Indexed keywords

ESTRADIOL; MESSENGER RNA; MICRORNA 143; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN E7; MICRORNA; MIRN143 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; PTEN PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BCL2 GENE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTEN GENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY;

ANIMALS; CELL LINE, TUMOR; CERVIX UTERI; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; PAPILLOMAVIRUS E7 PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84978390218     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3575     Document Type: Article

References (58)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. zur Hausen H: Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2: 342-350, 2002.
3. Crosbie EJ, Einstein MH, Franceschi S and Kitchener HC: Human papillomavirus and cervical cancer. Lancet 382: 889-899, 2013.
4. Münger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, Grace M and Huh K: Mechanisms of human papillomavirus-induced oncogenesis. J Virol 78: 11451-11460, 2004.
5. Riley RR, Duensing S, Brake T, Münger K, Lambert PF and Arbeit JM: Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 63: 4862-4871, 2003.
6. McLaughlin-Drubin ME and Münger K: The human papillomavirus E7 oncoprotein. Virology 384: 335-344, 2009.
7. Ghittoni R, Accardi R, Hasan U, Gheit T, Sylla B and Tommasino M: The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 40: 1-13, 2010.
8. Nilsson S, Mäkelä S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M and Gustafsson JA: Mechanisms of estrogen action. Physiol Rev 81: 1535-1565, 2001.
9. Gruber CJ, Tschugguel W, Schneeberger C and Huber JC: Production and actions of estrogens. N Engl J Med 346: 340-352, 2002.
10. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. Z hang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
12. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y and Takahashi T: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005.
13. Jovanovic M and Hengartner MO: miRNAs and apoptosis: RNAs to die for. Oncogene 25: 6176-6187, 2006.
14. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
16. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002.
17. McBee WC, Gardiner AS, Edwards RP, Lesnock JL and Bhargava R: MicroRNA analysis in human papillomavirus (HPV)-associated cervical neoplasia and cancer. J Carcinog Mutagen 1: 1-9, 2011.
18. Pereira PM, Marques JP, Soares AR, Carreto L and Santos MAS: MicroRNA expression variability in human cervical tissues. PLoS One 5: e11780, 2010.
19. Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, Lu W, Wan X, Ma D and Xie X: Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 224: 484-495, 2011.
20. Lui WO, Pourmand N, Patterson BK and Fire A: Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 67: 6031-6043, 2007.
21. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C and Zheng ZM: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557, 2008.
22. Gómez-Gómez Y, Organista-Nava J and Gariglio P: Deregulation of the miRNAs expression in cervical cancer: Human papillomavirus implications. Biomed Res Int 2013: 407052, 2013. doi: 10.1155/2013/407052.
23. Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, Hawes SE and Kiviat NB: Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One 6: e28423, 2011.
24. Liu L, Wang YL and Wang JF: Differential expression of miR-21, miR-126, miR-143, miR-373 in normal cervical tissue, cervical cancer tissue and Hela cell. Sichuan Da Xue Xue Bao Yi Xue Ban 43: 536-539, 2011 (in Chinese).
25. Yao Q, Xu H, Zhang QQ , Zhou H and Qu LH: MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun 388: 539-542, 2009.
26. Iliopoulos D, Jaeger SA, Hirsch HA, Bulyk ML and Struhl K: STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39: 493-506, 2010.
27. Liu L, Yu X, Guo X, Tian Z, Su M, Long Y, Huang C, Zhou F, Liu M, Wu X, et al: miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2. Mol Med Rep 5: 753-760, 2012.
28. Pillai MR, Halabi S, McKalip A, Jayaprakash PG, Rajalekshmi TN, Nair MK and Herman B: The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer. Cancer Epidemiol Biomarkers Prev 5: 329-335, 1996.
29. Dimitrakakis C, Kymionis G, Diakomanolis E, Papaspyrou I, Rodolakis A, Arzimanoglou I, Leandros E and Michalas S: The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions. Gynecol Oncol 77: 129-136, 2000.
30. Myklebust MP, Bruland O, Fluge Ø, Skarstein A, Balteskard L and Dahl O: MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. Br J Cancer 105: 1719-1725, 2011.
31. Zhang S, Liu F, Mao X, Huang J, Yang J, Yin X, Wu L, Zheng L and Wang Q: Elevation of miR-27b by HPV16 E7 inhibits PPAR? expression and promotes proliferation and invasion in cervical carcinoma cells. Int J Oncol 47: 1759-1766, 2015.
32. Bhat-Nakshatri P, Wang G, Collins NR, Thomson MJ, Geistlinger TR, Carroll JS, Brown M, Hammond S, Srour EF, Liu Y, et al: Estradiol-regulated microRNAs control estradiol response in breast cancer cells. Nucleic Acids Res 37: 4850-4861, 2009.
33. Herber R, Liem A, Pitot H and Lambert PF: Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol 70: 1873-1881, 1996.
34. Nolan T, Hands RE and Bustin SA: Quantification of mRNA using real-time RT-PCR. Nat Protoc 1: 1559-1582, 2006.
35. Arbeit JM, Howley PM and Hanahan D: Chronic estrogeninduced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci USA 93: 2930-2935, 1996.
36. International Collaboration of Epidemiological Studies of Cervical Cancer: Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer 120: 885-891, 2007.
37. Gocze K, Gombos K, Kovacs K, Juhasz K, Gocze P and Kiss I: MicroRNA expressions in HPV-induced cervical dysplasia and cancer. Anticancer Res 35: 523-530, 2015.
38. Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R and Haqq C: Optimized highthroughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5: 24, 2006.
39. Yao T and Lin Z: MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochim Biophys Acta 1822: 248-260, 2012.
40. Qin X, Yan L, Zhao X, Li C and Fu Y: microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett 4: 1290-1296, 2012.
41. Xu J, Zhang W, Lv Q and Zhu D: Overexpression of miR-21 promotes the proliferation and migration of cervical cancer cells via the inhibition of PTEN. Oncol Rep 33: 3108-3116, 2015.
42. Jeong YJ, Noh EM, Lee YR, Yu HN, Jang KY, Lee SJ, Kim J and Kim JS: 17beta-estradiol induces up-regulation of PTEN and PPARgamma in leiomyoma cells, but not in normal cells. Int J Oncol 36: 921-927, 2010.
43. Marino M, Acconcia F and Trentalance A: Biphasic estradiolinduced AKT phosphorylation is modulated by PTEN via MAP kinase in HepG2 cells. Mol Biol Cell 14: 2583-2591, 2003.
44. Yuan H, Ito S, Senga T, Hyodo T, Kiyono T, Kikkawa F and Hamaguchi M: Human papillomavirus type 16 oncoprotein E7 suppresses cadherin-mediated cell adhesion via ERK and AP-1 signaling. Int J Oncol 35: 309-314, 2009.
45. Miñano A, Xifró X, Pérez V, Barneda-Zahonero B, Saura CA and Rodríguez-Alvarez J: Estradiol facilitates neurite maintenance by a Src/Ras/ERK signalling pathway. Mol Cell Neurosci 39: 143-151, 2008.
46. Eferl R and Wagner EF: AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 3: 859-868, 2003.
47. Kakehashi A, Tago Y, Yoshida M, Sokuza Y, Wei M, Fukushima S and Wanibuchi H: Hormonally active doses of isoflavone aglycones promote mammary and endometrial carcinogenesis and alter the molecular tumor environment in Donryu rats. Toxicol Sci 126: 39-51, 2012.
48. Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K and Iba H: miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 378: 492-504, 2008.
49. Vázquez-Ulloa E, Lizano M, Avilés-Salas A, Alfaro-Moreno E and Contreras-Paredes A: Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer. Gynecol Oncol 122: 663-668, 2011.
50. Leslie NR and Downes CP: PTEN: The down side of PI 3-kinase signalling. Cell Signal 14: 285-295, 2002.
51. Bader AG, Kang S, Zhao L and Vogt PK: Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5: 921-929, 2005.
52. Menges CW, Baglia LA, Lapoint R and McCance DJ: Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res 66: 5555-5559, 2006.
53. Guo RX, Wei LH, Tu Z, Sun PM, Wang JL, Zhao D, Li XP and Tang JM: 17 estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. J Steroid Biochem Mol Biol 99: 9-18, 2006.
54. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582, 2008.
55. Du J, Chen GG, Vlantis AC, Chan PKS, Tsang RKY and van Hasselt CA: Resistance to apoptosis of HPV 16-infected laryngeal cancer cells is associated with decreased Bak and increased Bcl-2 expression. Cancer Lett 205: 81-88, 2004.
56. Perillo B, Sasso A, Abbondanza C and Palumbo G: 17estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20: 2890-2901, 2000.
57. Zhang X, Liu S, Hu T, Liu S, He Y and Sun S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50: 490-499, 2009.
58. Spitkovsky D, Hehner SP, Hofmann TG, Möller A and Schmitz ML: The human papillomavirus oncoprotein E7 attenuates NF-B activation by targeting the Ikappa B kinase complex. J Biol Chem 277: 25576-25582, 2002.